Latest TSHA reports update at 2024-05-14: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Taysha Gene Therapies
  4. Financial Ratios
  5. EV/EBITDA Ratio
Taysha Gene Therapies logo
Taysha Gene Therapies TSHA
$ 4.17 6.65%
mail-toReport an Error

Taysha Gene Therapies EV/EBITDA Ratio 2011-2024 | TSHA

Annual EV/EBITDA Ratio Taysha Gene Therapies

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.13 -1.25 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.13 -1.25 -1.19